Literature DB >> 33989274

Recently approved drugs herald a new era in therapy for diffuse large B-cell lymphoma.

Grzegorz S Nowakowski1,2.   

Abstract

Entities:  

Year:  2021        PMID： 33989274

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  1 in total

Review 1.  Molecular Aspects of Resistance to Immunotherapies-Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma.

Authors:  Aleksandra Kusowska; Matylda Kubacz; Marta Krawczyk; Aleksander Slusarczyk; Magdalena Winiarska; Malgorzata Bobrowicz
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.